Malaria research has been advancing rapidly in recent years, and now there\’s even more hope: scientists have developed a vaccine that can slash malaria incidence by half, and it could be introduced to the world\’s worst-hit countries by 2015.

The vaccine—called RTS,S and developed by GlaxoSmithKline—has been shown to halve the cases of malaria among children aged between five and seven months, as well as cutting the number of cases in babies aged 6 to 12 weeks by a quarter. The results were unveiled this morning in Durban, South Africa.

via A Working Malaria Vaccine Could Be Used In Developing Countries By 2015.